The University of Chicago Header Logo

Connection

Ann M. Zmuda to Platelet Aggregation

This is a "connection" page, showing publications Ann M. Zmuda has written about Platelet Aggregation.
Connection Strength

0.145
  1. Dihomo-gamma-linolenic acid in patients with atherosclerosis: effects on platelet aggregation, plasma lipids and low-density lipoprotein-induced inhibition of prostacyclin generation. Thromb Haemost. 1984 Apr 30; 51(2):186-8.
    View in: PubMed
    Score: 0.062
  2. Experimental atherosclerosis in rabbits: platelet aggregation, thromboxane A2 generation and anti-aggregatory potency of prostacyclin. Prostaglandins. 1977; 14(6):1035-42.
    View in: PubMed
    Score: 0.037
  3. Eicosanoid balance at early stages of experimental atherosclerosis. Its relationship with plasma fibrinolytic activity and platelet aggregation. Agents Actions Suppl. 1986; 20:225-36.
    View in: PubMed
    Score: 0.017
  4. Increased platelet activity after termination of prostacyclin infusion into man. Prostaglandins. 1981 May; 21(5):827-32.
    View in: PubMed
    Score: 0.013
  5. Selective inhibition of thromboxane A2 biosynthesis in blood platelets. Nature. 1977 Jun 16; 267(5612):627-8.
    View in: PubMed
    Score: 0.010
  6. Prostacyclin and thromboxane A2 biosynthesis capacities of heart, arteries and platelets at various stages of experimental atherosclerosis in rabbits. Atherosclerosis. 1978 Dec; 31(4):385-94.
    View in: PubMed
    Score: 0.003
  7. Prostacyclin formation by myometrial & decidual fractions of the pregnant rat uterus. Prostaglandins. 1978 Feb; 15(2):343-50.
    View in: PubMed
    Score: 0.002
  8. A potent inhibitor of thromboxane A2 biosynthesis in aggregating human blood platelets. Pharmacol Res Commun. 1977 Feb; 9(2):109-16.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.